| Aktie | Ticker | Breite | GCS | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 16.369.175 $ | +10.718.167 $ | +124,1 % | 8 | 19.553.783 $ | +3.359.767 $ | -0,7 % | 11 | ||||
| HilleVax, Inc. | → 0 | 13.381.160 $ | +3.630.960 $ | +37,2 % | 1 | ||||||
| Ovid Therapeutics Inc. | OVID | → 0 | Neutral | 9.791.595 $ | +7.306.215 $ | +294,0 % | 1 | 2.485.380 $ | +135.575 $ | +5,8 % | 1 |
| Equillium, Inc. | EQ | → 0 | Schwach | 2.609.717 $ | +2.034.484 $ | +353,7 % | 1 | 575.233 $ | -136.508 $ | -19,2 % | 1 |
| Xilio Therapeutics, Inc. | XLO | → 0 | Neutral | 1.243.084 $ | +240.149 $ | +23,9 % | 1 | 1.002.935 $ | -65.053 $ | -6,1 % | 1 |
| Shattuck Labs, Inc. | STTK | → 0 | Schwach | 1.232.329 $ | +824.062 $ | +201,8 % | 1 | 408.267 $ | -81.571 $ | -16,7 % | 1 |
| Lyell Immunopharma, Inc. | LYEL | → 0 | Neutral | 891.365 $ | +527.459 $ | +144,9 % | 1 | 363.906 $ | -79.039 $ | -17,8 % | 1 |
| American Well Corp | AMWL | → 0 | Schwach | 478.061 $ | -212.989 $ | -30,8 % | 1 | 691.050 $ | +78.511 $ | +12,8 % | 1 |
| Turnstone Biologics Corp. | → 0 | 321.601 $ | -45.687 $ | -12,4 % | 1 | ||||||
| Third Harmonic Bio, Inc. | → 0 | 200.014 $ | +72.197 $ | +56,5 % | 1 | ||||||
| Rani Therapeutics Holdings, Inc. | RANI | → 0 | Neutral | 101.554 $ | -2.865 $ | -2,7 % | 1 | 104.419 $ | -151.600 $ | -59,2 % | 1 |
| STANDARD BIOTOOLS INC. | LAB | → 0 | Schwach | 21.470 $ | +1.652 $ | +8,3 % | 1 | 19.818 $ | +1.982 $ | +11,1 % | 1 |
| 16.369.175 $ | +10.718.167 $ | +124,1 % | 8 | 19.553.783 $ | +3.359.767 $ | -0,7 % | 11 | ||||